Archive for the 'Lymphoma / Leukemia' Category
Quality Of Life Issues For Patients With Chronic Myeloid Leukemia
Although significant progress has been made in treating chronic myeloid leukemia, the disease cannot yet be eliminated in all patients, and that challenge must be addressed, states a commentary in CMAJ (Canadian Medical Association Journal).). Likening the journey to find a cure for chronic myeloid leukemia as a marathon, cancer expert Dr…
Original post by Wife of a Diabetic
No commentsIn Acute Myeloid Leukemia Study Pinpoints And Plugs Mechanism Of Cancer Cell Escape
A study published this week in the journal Leukemia identifies a mechanism that acute myeloid leukemia (AML) cells use to evade chemotherapy – and details how to close this escape route…
Original post by Wife of a Diabetic
No commentsPotential New Approach For Treating Graft-Versus-Host-Disease Provided By Natural Enzyme
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants. Researchers from the University of Michigan Comprehensive Cancer Center looked at the drug alpha-1-antitrypsin, which is approved by the U.S…
Original post by Wife of a Diabetic
No commentsNew Achilles Heel In Acute Myeloid Leukaemia Identified By Cell Death Researchers
Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1…
Original post by Wife of a Diabetic
No commentsStudy Published On Novel Treatment For Skin Lymphoma
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are published in JAMA’s Archives of Dermatology by clinical researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine…
Original post by Wife of a Diabetic
No commentsNewly Identified Genetic Alterations In T-ALL Provide New Potential Treatment Strategies For Devastating Childhood Leukemia
A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 (PRC2) protein complex, work together to cause T- cell acute lymphoblastic leukemia (T-ALL). T-ALL is an aggressive blood cancer, predominately diagnosed in children…
Original post by Wife of a Diabetic
No commentsLeukemia Relapse May Be Influenced By Chemotherapy
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest. The research, by a team of physicians and scientists at Washington University School of Medicine in St. Louis, is published in the advance online edition of Nature…
Original post by Wife of a Diabetic
No commentsProtein Inhibitor Has Potent Anti-Tumor Effects, May Offer More Effective Treatment For Multiple Myeloma
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer. Despite aggressive modes of treatments, myeloma ultimately remains incurable. The disease has a high incidence in the communities served by SUNY Downstate…
Original post by Wife of a Diabetic
No commentsNews From The Journal Of Clinical Investigation: Jan. 9, 2012
ONCOLOGY: KRAS provides maintenance for pancreatic cancer The outlook for individuals diagnosed with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (PDA), is very poor; the average time of survival after diagnosis is less than 6 months. New therapeutic approaches are therefore much needed…
Original post by Wife of a Diabetic
No comments